Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track M9140's trials
Anti-CEACAM5 ADC Precemtabart Tocentecan (M9140) in Chinese Participants With Solid Tumors
M9140
Ongoing
Active not recruiting
Phase 1
Open NCT06806046 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record
NCT06806046 · Trial Tracker · ComplyRx
